Cargando…

Risk score predicts high‐grade prostate cancer in DNA‐methylation positive, histopathologically negative biopsies

BACKGROUND: Prostate cancer (PCa) diagnosis is challenging because efforts for effective, timely treatment of men with significant cancer typically result in over‐diagnosis and repeat biopsies. The presence or absence of epigenetic aberrations, more specifically DNA‐methylation of GSTP1, RASSF1, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Neste, Leander, Partin, Alan W., Stewart, Grant D., Epstein, Jonathan I., Harrison, David J., Van Criekinge, Wim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111760/ https://www.ncbi.nlm.nih.gov/pubmed/27121847 http://dx.doi.org/10.1002/pros.23191

Ejemplares similares

A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection
por: Van Neste, Leander, et al.
Publicado: (2012)

PubMeth: a cancer methylation database combining text-mining and expert annotation
por: Ongenaert, Maté, et al.
Publicado: (2008)

Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American Men
por: Waterhouse, Robert L., et al.
Publicado: (2019)

Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients
por: Mischinger, Johannes, et al.
Publicado: (2022)

Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports
por: Minnee, Pieter, et al.
Publicado: (2019)

Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies
por: Margolis, Erik, et al.
Publicado: (2021)

Evaluation of an RNAseq-Based Immunogenomic Liquid Biopsy Approach in Early-Stage Prostate Cancer
por: Van Neste, Leander, et al.
Publicado: (2021)

Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer
por: Stewart, Grant D., et al.
Publicado: (2016)

DNA methylation in repeat negative prostate biopsies as a marker of missed prostate cancer
por: Fiano, Valentina, et al.
Publicado: (2019)

Biopsy interpretation of the prostate
por: Epstein, Jonathan I.

Prostate biopsy interpretation
por: Epstein, Jonathan I.

Prognostic Histopathological and Molecular Markers on Prostate Cancer Needle-Biopsies: A Review
por: Hoogland, A. Marije, et al.
Publicado: (2014)

Histopathologic Review of Previously Negative Prostatic Core Needle Biopsies Following a New Diagnosis of Adenocarcinoma of the Prostate by Core Needle Biopsies: Implications for Quality Assurance Programs
por: Patel, Jay, et al.
Publicado: (2008)

DNA methylation profiling of primary neuroblastoma tumors using methyl-CpG-binding domain sequencing
por: Decock, Anneleen, et al.
Publicado: (2016)

MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data
por: Koch, Alexander, et al.
Publicado: (2015)

The histopathological synovitis score is influenced by biopsy location in patients with knee osteoarthritis
por: Mussawy, Haider, et al.
Publicado: (2021)

Analysis of Prostate Adenocarcinoma Histopathological Types in Relation to Tumor Grade
por: PĂNUŞ, ANDREI, et al.
Publicado: (2020)

Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients
por: Ryoo, Hyunsoo, et al.
Publicado: (2020)

Prostate Cancer in Patients with Metabolic Syndrome Is Associated with Low Grade Gleason Score When Diagnosed on Biopsy
por: Jeon, Kyoung Pil, et al.
Publicado: (2012)

A Nomogram Based on a TRUS Five-Grade Scoring System for the Prediction of Prostate Cancer and High Grade Prostate Cancer at Initial TRUS-Guided Biopsy
por: Xie, Shao Wei, et al.
Publicado: (2018)

A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy
por: McKiernan, James, et al.
Publicado: (2020)

Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists
por: Bulten, Wouter, et al.
Publicado: (2020)

Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy
por: Fiorentino, Vincenzo, et al.
Publicado: (2020)

The percentage of high‐grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death
por: Berney, Daniel M, et al.
Publicado: (2019)

Histopathological grading and DNA ploidy as prognostic markers in metastatic prostatic cancer.
por: Jørgensen, T., et al.
Publicado: (1995)

Histopathological Study of the Prostate Cancer Growth Patterns in Relation with the Grading Systems
por: POPESCU, TUDOR CRISTIAN TIMOTEI, et al.
Publicado: (2022)

Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK population
por: Rochester, Mark A, et al.
Publicado: (2009)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
por: Lee, Kwang Suk, et al.
Publicado: (2017)

Percentage Gleason pattern 4 and PI-RADS score predict upgrading in biopsy Grade Group 2 prostate cancer patients without cribriform pattern
por: van der Slot, Margaretha A., et al.
Publicado: (2022)

Label Distribution Learning for Automatic Cancer Grading of Histopathological Images of Prostate Cancer
por: Nishio, Mizuho, et al.
Publicado: (2023)

Deep learning for automatic Gleason pattern classification for grade group determination of prostate biopsies
por: Lucas, Marit, et al.
Publicado: (2019)

Acute and chronic histopathological findings in renal biopsies in COVID-19
por: Volbeda, Meint, et al.
Publicado: (2022)

The Correlation between Diffusion-Weighted Imaging and Histopathological Evaluation of 356 Prostate Biopsy Sites in Patients with Prostatic Diseases
por: Kilinç, R., et al.
Publicado: (2012)

Prognostic Characterization of Higher-Grade Meningiomas: A Histopathological Score to Predict Progression and Outcome
por: Bertero, Luca, et al.
Publicado: (2019)

Evaluation of bisulfite kits for DNA methylation profiling in terms of DNA fragmentation and DNA recovery using digital PCR
por: Kint, Sam, et al.
Publicado: (2018)

Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3
por: Boers, A., et al.
Publicado: (2016)

Neuroendocrine Differentiation In Prostate Adenocarcinoma Biopsies And Its Correlation To Histological Grading
por: Marcu, Mădălina, et al.
Publicado: (2010)

Grading of prostatic adenocarcinoma: current state and prognostic implications
por: Gordetsky, Jennifer, et al.
Publicado: (2016)

Cascaded discrimination of normal, abnormal, and confounder classes in histopathology: Gleason grading of prostate cancer
por: Doyle, Scott, et al.
Publicado: (2012)

Evaluation of Tumor Heterogeneity of Prostate Carcinoma by Flow- and Image DNA Cytometry and Histopathological Grading
por: Wang, Naining, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_g6pekjljg3gubeub51va1445oj